Back to Search
GEORGE GUSTAFSON, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1689669483IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
43485(CO)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
R FRANKLIN UNIVERSITY OF MED & SCI/CHICAGO MEDICAL SCHOOL
Class of 1977
Research & Publications (20)
Host perception and signal transduction studies in wild-type Blumeria graminis f. sp. hordei and a quinoxyfen-resistant mutant implicate quinoxyfen in the inhibition of serine esterase activity.
PMID 18229890·Pest Manag Sci·2008
8-other
Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study.
PMID 17967304·Int J Radiat Oncol Biol Phys·2007
3-trial
Matched-pair analysis of prostate cancer patients with a high risk of positive pelvic lymph nodes treated with and without pelvic RT and high-dose radiation using high dose rate brachytherapy.
PMID 17023778·Am J Clin Oncol·2006
8-other
High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study.
PMID 16879929·Int J Radiat Oncol Biol Phys·2006
3-trial
Sensitivity of Uncinula necator to quinoxyfen: evaluation of isolates selected using a discriminatory dose screen.
PMID 16612812·Pest Manag Sci·2006
8-other
Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer. Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups?
PMID 16520907·Strahlenther Onkol·2006
8-other
Butenyl-spinosyns, a natural example of genetic engineering of antibiotic biosynthetic genes.
PMID 16179985·J Ind Microbiol Biotechnol·2006
8-other
A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
PMID 16093980·J Urol·2005
4-observational
A systems approach to assess farm-scale nutrient and trace element dynamics: a case study at the Ojebyn dairy farm.
PMID 16092260·Ambio·2005
7-preclinical
Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
PMID 16029788·Int J Radiat Oncol Biol Phys·2005
4-observational
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
PMID 16029785·Int J Radiat Oncol Biol Phys·2005
3-trial
A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
PMID 15667959·Int J Radiat Oncol Biol Phys·2005
3-trial
Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
PMID 15474426·Am J Surg·2004
8-other
System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner.
PMID 15334592·Magn Reson Med·2004
8-other
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner.
PMID 15275727·Int J Radiat Oncol Biol Phys·2004
8-other
Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.
PMID 15001244·Int J Radiat Oncol Biol Phys·2004
3-trial
High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
PMID 14767279·J Urol·2004
4-observational
Current status of zirconia used in total hip implants.
PMID 14652396·J Bone Joint Surg Am·2003
6-review
No apparent benefit at 5 years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose.
PMID 14634400·J Urol·2003
8-other
Inter-society standards for the performance of brachytherapy: a joint report from ABS, ACMP and ACRO.
PMID 14585480·Crit Rev Oncol Hematol·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1400 E BOULDER ST, SUITE 700
COLORADO SPRINGS, CO 80909 - Phone
- (719) 635-7172
Quick Facts
- NPI
- 1689669483
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 49
- Publications
- 20
Are you this provider?
Claim Your Profile